{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T19:28:25Z","timestamp":1651519705586},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rehabilitation (Stuttg)"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\nZiel der Studie Die Medikamentenadh\u00e4renz von Menschen mit chronischen Erkrankungen ist h\u00e4ufig defizit\u00e4r. Die vorliegende Studie untersuchte F\u00f6rderfaktoren und Barrieren bez\u00fcglich der Umsetzung von \u00e4rztlich verordneter Medikation bei Rehabilitanden mit kardiologischen Erkrankungen in der medizinischen Rehabilitation.<\/jats:p><jats:p>\nMethodik Es wurden N=22 Rehabilitanden mit kardiologischen Erkrankungen in der medizinischen Rehabilitation mithilfe eines leitfadengest\u00fctzten Interviews befragt. Alle Interviews wurden digital aufgezeichnet und w\u00f6rtlich transkribiert. Die Analyse der Interviews erfolgte softwaregest\u00fctzt (MAXQDA 12) nach dem zusammenfassenden inhaltsanalytischen Ansatz von Mayring. Die Hauptkategorien (Barrieren\/F\u00f6rderfaktoren) wurden deduktiv und die Subkategorien induktiv entwickelt.<\/jats:p><jats:p>\nErgebnisse Insgesamt wurden 698 Textstellen in 22 Dokumenten codiert, im Durchschnitt 32 pro Interview (SD=13.2; Range 12\u201365). Die in der Hauptkategorie Barrieren vergebenen 370 Nennungen verteilen sich auf 13 Subkategorien (u.\u2009a. Sorglosigkeit, Mangelnde Informiertheit, Vorbehalte, Belastungen, Vergesslichkeit). Die in der Hauptkategorie F\u00f6rderfaktoren vergebenen 328 Aussagen konnten 14 Subkategorien zugeordnet werden (u.\u2009a. Individuelle Strategien, Informiertheit, Hilfsmittel, Behandlungseinsicht, Kommunikation).<\/jats:p><jats:p>\nSchlussfolgerung Die Befunde legen nahe, dass eine mangelnde Medikamentenadh\u00e4renz v.\u2009a. durch ein individualisiertes Barrierenmanagement, das auf mehreren Ebenen ansetzen muss, verbessert werden kann.<\/jats:p>","DOI":"10.1055\/a-1242-9562","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:06:40Z","timestamp":1604621200000},"page":"37-44","source":"Crossref","is-referenced-by-count":1,"title":["F\u00f6rderfaktoren und Barrieren der Medikamentenadh\u00e4renz von Rehabilitanden mit kardiologischen Erkrankungen \u2013 Eine qualitative Befragung"],"prefix":"10.1055","volume":"60","author":[{"given":"Katharina","family":"Quaschning","sequence":"additional","affiliation":[{"name":"Medizinische Fakult\u00e4t, Medizinische Psychologie und Medizinische Soziologie, Albert-Ludwigs-Universit\u00e4t Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"K\u00f6rner","sequence":"additional","affiliation":[{"name":"Medizinische Fakult\u00e4t, Medizinische Psychologie und Medizinische Soziologie, Albert-Ludwigs-Universit\u00e4t Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1055\/s-0031-1281566","article-title":"Strategien zur Verbesserung der Einnahmetreue von Medikamenten","volume":"136","author":"U Laufs","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"key":"ref2","first-page":"557","article-title":"Arterial Hypertension","volume":"115","author":"J Jordan","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11428-015-1399-5","article-title":"Die Therapietreue beeinflussenden Faktoren bei der Einnahme von Diabetesmedikamenten","volume":"11","author":"M Jecht","year":"2015","journal-title":"Diabetologe"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"M C Sokol","year":"2005","journal-title":"Med Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","article-title":"Non-adherence to cardiovascular medications","volume":"35","author":"K Kolandaivelu","year":"2014","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/S0140-6736(05)67760-4","article-title":"Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme. Double-blind, randomised, controlled clinical trial","volume":"366","author":"B B Granger","year":"2005","journal-title":"The Lancet"},{"key":"ref9","first-page":"41","article-title":"Improving adherence with medication: A selective literature review based on the example of hypertension treatment","volume":"111","author":"J Matthes","year":"2014","journal-title":"Dtsch Arztebl Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial","volume":"310","author":"S Thom","year":"2013","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijcard.2016.06.263","article-title":"Medication adherence and persistence according to different antihypertensive drug classes. A retrospective cohort study of 255,500 patients","volume":"220","author":"M Schulz","year":"2016","journal-title":"International Journal of Cardiology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis","volume":"176","author":"J Thakkar","year":"2016","journal-title":"JAMA Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.18553\/jmcp.2013.19.5.396","article-title":"Reducing cardiovascular medication complexity in a German university hospital: Effects of a structured pharmaceutical management intervention on adherence.","volume":"19","author":"D Stange","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: Its importance in cardiovascular outcomes","volume":"119","author":"P M Ho","year":"2009","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/HJH.0b013e328342ca97","article-title":"Better compliance to antihypertensive medications reduces cardiovascular risk","volume":"29","author":"G Corrao","year":"2011","journal-title":"J Hypertens"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.297.2.177","article-title":"Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction","volume":"297","author":"J N Rasmussen","year":"2007","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e009235","DOI":"10.1136\/bmjopen-2015-009235","article-title":"Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review","volume":"5","author":"J A Cooper","year":"2015","journal-title":"BMJ Open"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/bcp.12734","article-title":"Oral antineoplastic agents: how do we care about adherence?","volume":"80","author":"M Barillet","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"ref19","volume-title":"Praxisbuch Interview, Transkription & Analyse. Anleitungen und Regelsysteme f\u00fcr qualitativ Forschende","author":"T Dresing","year":"2018"},{"key":"ref20","volume-title":"Qualitative Inhaltsanalyse. Grundlagen und Techniken","author":"P Mayring","year":"2015"},{"key":"ref21","volume-title":"Einf\u00fchrung in die qualitative Sozialforschung. Eine Anleitung zu qualitativem Denken. 6. Aufl","author":"P Mayring","year":"2016"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/a-0801-5465","article-title":"Die Qualitative Inhaltsanalyse","volume":"58","author":"N J Pohontsch","year":"2019","journal-title":"Rehabilitation (Stuttg)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"A Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"ref24","volume-title":"Qualitative Inhaltsanalyse. Methoden, Praxis, Computerunterst\u00fctzung","author":"U Kuckartz","year":"2018"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-41089-5","volume-title":"Forschungsmethoden und Evaluation in den Sozial- und Humanwissenschaften","author":"N D\u00f6ring","year":"2016"}],"container-title":["Die Rehabilitation"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1242-9562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:43:32Z","timestamp":1612831412000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1242-9562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":23,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2021,2,8]]},"published-print":{"date-parts":[[2021,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1242-9562","relation":{},"ISSN":["0034-3536","1439-1309"],"issn-type":[{"value":"0034-3536","type":"print"},{"value":"1439-1309","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}